Based on the Clinical Global Impression Scale for Bipolar Disorder, patients were classified into 3 groups.
根据双相情感障碍的临床综合印象量表,患者被分成了3组。
RESULTS: Actovegin group showed much higher rates of improvement in cognitive function and clinical global impression than those of placebo group (P< 0.01).
结果:爱维治组在认知功能、临床总体疗效方面改善率均显著高于安慰剂组(P<0.01),爱维治组日常生活功能也较治疗前有明显提高(P<0.01)。
RESULTS: Actovegin group showed much higher rates of improvement in cognitive function and clinical global impression than those of placebo group (P< 0.01).
结果:爱维治组在认知功能、临床总体疗效方面改善率均显著高于安慰剂组(P<0.01),爱维治组日常生活功能也较治疗前有明显提高(P<0.01)。
应用推荐